insights_auto
Outlook: 39.4% bullish·15.2% bearish
Go to analysischevron_right
ARGX:NASDAQ
argenx SE - ADR
၈၁၆.၉၀ US$
arrow_downward
-၀.၉၈%(-၈.၁၂) 1D
အောက် ၁၂, GMT-၄ ၁၂:၄၁:၂၀ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
၈၃၂.၃၃ US$
High
၈၃၂.၄၉ US$
Low
၈၁၁.၉၀ US$
Mkt. cap
ဋေ ၅.၀၈ ထ
Avg. vol.
၃.၄၀ သိန်း
Volume
၉.၀၅ သောင်း
P/E ratio
၃၁.၀၄
52-wk high
၁,၀၇၂.၇၅ US$
52-wk low
၆၆၁.၈၅ US$
EPS
၂၆.၃၂ US$
Beta
၀.၄၅
Shares outstanding
၆.၂၉ ကုဋေ
No. of employees
၂ ထောင်
Open
၈၃၂.၃၃ US$
High
၈၃၂.၄၉ US$
Low
၈၁၁.၉၀ US$
Mkt. cap
ဋေ ၅.၀၈ ထ
Avg. vol.
၃.၄၀ သိန်း
Volume
၉.၀၅ သောင်း
P/E ratio
၃၁.၀၄
52-wk high
၁,၀၇၂.၇၅ US$
52-wk low
၆၆၁.၈၅ US$
EPS
၂၆.၃၂ US$
Beta
၀.၄၅
Shares outstanding
၆.၂၉ ကုဋေ
No. of employees
၂ ထောင်
News stories
From web sources and news partners
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၄ နာရီ
Argenx stock at EUR 745.20, 0.05 percent below its recent high
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၈ နာရီ
Argenx halts UNITY study. Argenx stock trades 1.18 percent higher
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၁၁ နာရီ
argenx stock pre-market at EUR 734.10
Yahoo Finance
·
ပြီးခဲ့သည့် ၂ ရက်
argenx (ENXTBR:ARGX) Stock May Be Fully Priced After Its 185% Run
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE - ADR